Apr 17, 2023

Author of the article: Article content The project is building the first federated and fully protected global network for sharing genomics and biomedical data We apologize, but this video has failed to load. Try refreshing your browser, or integrate.ai Announces Central Role in Ground-Breaking Software Platform for Genomics and Precision Health Back to video CHICAGO — integrate.ai , a SaaS company helping organizations solve the world’s most important problems without risking the world’s most sensitive data, today announced its central role in the Canadian Platform for Genomics and Precision Health (CP4GPH), funded in part by Digital . Together with partner DNAstack, the platform will help deliver better outcomes for Canadians by making it easier to derive AI-powered discoveries across networks of data in neuroscience, oncology, rare disease, infectious disease, health care, agriculture, and beyond. Advertisement 2 THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLY Subscribe now to read the latest news in your city and across Canada. Unlimited online access to articles from across Canada with one account Get exclusive access to the National Post ePaper, an electronic replica of the print edition that you can share, download and comment on Enjoy insights and behind-the-scenes analysis from our award-winning journalists Support local journalists and the next generation of journalists Daily puzzles including the New York Times Crossword SUBSCRIBE TO UNLOCK MORE ARTICLES Subscribe now to read the latest news in your city and across Canada. Unlimited online access to articles from across Canada with one account Get exclusive access to the National Post ePaper, an electronic replica of the print edition that you can share, download and comment on Enjoy insights and behind-the-scenes analysis from our award-winning journalists Support local journalists and the next generation of journalists Daily puzzles including the New York Times Crossword REGISTER TO UNLOCK MORE ARTICLES Create an account or sign in to continue with your reading experience. Access articles from across Canada with one account Share your thoughts and join the conversation in the comments Enjoy additional articles per month Get email updates from your favourite authors or Article content Financial Post Top Stories Sign up to receive the daily top stories from the Financial Post, a division of Postmedia Network Inc. Email Address Sign Up By clicking on the sign up button you consent to receive the above newsletter from Postmedia Network Inc. You may unsubscribe any time by clicking on the unsubscribe link at the bottom of our emails or any newsletter. Postmedia Network Inc. | 365 Bloor Street East, Toronto, Ontario, M4W 3L4 | 416-383-2300 Thanks for signing up! A welcome email is on its way. If you don't see it, please check your junk folder. The next issue of Financial Post Top Stories will soon be in your inbox. We encountered an issue signing you up. Please try again Article content Scientists, clinicians, researchers and AI algorithms need large and diverse datasets to uncover innovative precision health solutions. The current approach to data centralization has made it nearly impossible to safely and accurately analyze the large amounts of data needed to make these discoveries. Ever-evolving regulations have also restricted researchers’ access to quality patient data, further limiting advances in this space. “Traditional approaches like centralized data sharing are inefficient, insecure and impractical for sensitive health data. integrate.ai’s software enables AI and analytic work across sensitive data silos without needing to move the data, providing maximum protection and unblocking critical innovation in genomics and precision health,” said Steve Irvine, founder and CEO of integrate.ai. “Canada’s biotech industry has made a considerable impact on the global stage, and this project will put Canada at the forefront of precision health – driving innovation, enabling job creation and cultivating high-value research and discovery.” The CP4GPH will enable privacy-preserving federated analytics and AI through integrate.ai’s technology, allowing researchers to safely activate data silos and derive insights across distributed datasets without sharing, moving, or providing direct access to data between organizations. Since the location and control of the data remains unchanged, privacy and security can be maintained and data can be utilized according to patient consent. The project will cultivate an open innovation ecosystem that additional stakeholders can plug into, and will ultimately commercialize globally-leading solutions to manage, share, analyze, and translate insights from genomics and health data. “We are committed to creating a world of possibilities in autism research by supporting critical projects like the Canadian Platform for Genomics and Precision Health,” said Evdokia Anagnostou, VP of Research at Holland Bloorview Kids Rehabilitation Hospital. “We are proud to lead innovative work through this initiative and we are indebted to participants in clinical trials that are accelerating meaningful discoveries for autistic individuals and their families.” By combining the latest standards for data interoperability with AI-powered technologies for federated learning, the CP4GPH is creating a new way for organizations to safely collaborate to unlock value from the world’s exponentially growing volumes of genomic and health data. Advertisement 3 Article content To learn more about this ground-breaking software platform, please visit their site or stop by to meet integrate.ai’s executive team during the global HIMSS conference from April 17-21, 2023 in Chicago, IL. About integrate.ai integrate.ai is a SaaS company helping organizations solve the world’s most important problems without risking the world’s most sensitive data. Through its safe data collaboration platform, integrate.ai empowers data science leaders to activate data silos and run federated analytics and AI workloads by moving models, not data. Armed with experience building data networks within enterprises across eight industries, integrate.ai enables organizations to safely accelerate access to secure, interoperable data and advance insights across critical use cases, including precision medicine, drug discovery, clinical trials, collaborative research, corporate data silos, risk underwriting, fraud detection, and more. View source version on businesswire.com: https://www.businesswire.com/news/home/20230417005121/en/ Contacts